Kitov Pharma Ltd ADR (NASDAQ:KTOV)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - KTOV

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - KTOV

  • Market Cap$128.180m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS49803V1070

Company Profile

Kitov Pharma Ltd is a development stage biopharmaceutical company. It focuses on the development of KIT-302, a combination drug for the simultaneous treatment of two clinical conditions pain caused by osteoarthritis and hypertension; and NT219 which is a fixed-dose combination of two drug products that treat osteoarthritis pain and hypertension simultaneously. The company's operating segment include Pain and Hypertension and Oncology, It generates maximum revenue from the Pain and Hypertension segment.Kitov Pharma Ltd is engaged in the development of a combination drug that aims to treat osteoarthritis (OA) pain and hypertension called KIT-302 and NT219.

Latest KTOV news

Currently there for this company. Visit our news hub for other news .